Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer (Q39340772)
Jump to navigation
Jump to search
scientific article published on 23 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer |
scientific article published on 23 January 2007 |
Statements
1 reference
Clinical benefit of bone-targeted radiometabolic therapy with 153Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer (English)
1 reference
Sergio Ricci
1 reference
Giuseppe Boni
1 reference
Ilaria Pastina
1 reference
Dario Genovesi
1 reference
Claudia Cianci
1 reference
Serena Chiacchio
1 reference
Cinzia Orlandini
1 reference
Mariano Grosso
1 reference
Abedallatif Alsharif
1 reference
Aldo Chioni
1 reference
Samantha Di Donato
1 reference
Francesco Francesca
1 reference
Cesare Selli
1 reference
Domenico Rubello
1 reference
Giuliano Mariani
1 reference
23 January 2007
1 reference
1 reference
34
1 reference
7
1 reference
1023-1030
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference